Tefibazumab

Modify Date: 2024-08-09 14:13:47

Tefibazumab structure	Common Name	Tefibazumab
	CAS Number	521079-87-8	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Tefibazumab

Tefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections[1][2].

Name	Tefibazumab

Description	Tefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections[1][2].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Others >> Others
In Vitro	Tefibazumab 具有由人 (>98%) 和鼠 (<2%) 氨基酸序列组成的可变抗原结合区。Tefibazumab 特异性识别金黄色葡萄球菌表达的 ClfA[2]。
References	[1]. pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug;50(8):2751-5. [2]. Reilley S, et, al. Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers. Antimicrob Agents Chemother. 2005 Mar;49(3):959-62.

No Any Chemical & Physical Properties

Tefibazumab

Use of Tefibazumab

Names

Tefibazumab Biological Activity

Chemical & Physical Properties